At the time of writing, Cg Oncology Inc. [CGON] stock is trading at $33.84, up 1.47%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The CGON shares have gain 2.58% over the last week, with a monthly amount glided 8.05%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Cg Oncology Inc. [NASDAQ: CGON] stock has seen the most recent analyst activity on June 28, 2024, when BofA Securities initiated its Buy rating and assigned the stock a price target of $65. Previously, Morgan Stanley started tracking the stock with Overweight rating on February 20, 2024, and set its price target to $55. On February 20, 2024, Goldman initiated with a Neutral rating and assigned a price target of $42 on the stock. Cantor Fitzgerald started tracking the stock assigning a Overweight rating and suggested a price target of $75 on February 20, 2024. H.C. Wainwright initiated its recommendation with a Buy and recommended $75 as its price target on February 14, 2024.
For the past year, the stock price of Cg Oncology Inc. fluctuated between $25.77 and $50.23. Currently, Wall Street analysts expect the stock to reach $50 within the next 12 months. Cg Oncology Inc. [NASDAQ: CGON] shares were valued at $33.84 at the most recent close of the market. An investor can expect a potential return of 47.75% based on the average CGON price forecast.
Analyzing the CGON fundamentals
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 32.58 points at the first support level, and at 31.32 for the second support level. However, for the 1st resistance point, the stock is sitting at 34.55, and for the 2nd resistance point, it is at 35.26.
Ratios To Look Out For
It is important to note that Cg Oncology Inc. [NASDAQ:CGON] has a current ratio of 57.95. Further, the Quick Ratio stands at 57.95.
Transactions by insiders
Recent insider trading involved Decheng Capital Global Life Sc, 10% Owner, that happened on Jan 29 ’24 when 0.4 million shares were purchased. Director, Song Hong Fang completed a deal on Jan 29 ’24 to buy 0.26 million shares. Meanwhile, CFO & Secretary Roche Corleen M. bought 2000.0 shares on Jan 29 ’24.
